Cherokee Insurance Co grew its holdings in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 16.0% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 9,400 shares of the company’s stock after buying an additional 1,300 shares during the quarter. HCA Healthcare comprises approximately 1.4% of Cherokee Insurance Co’s portfolio, making the stock its 24th largest holding. Cherokee Insurance Co’s holdings in HCA Healthcare were worth $4,011,000 as of its most recent SEC filing.
Several other institutional investors have also recently bought and sold shares of the stock. Sunbelt Securities Inc. boosted its stake in shares of HCA Healthcare by 171.7% in the 1st quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock valued at $2,954,000 after purchasing an additional 3,945 shares during the last quarter. Sei Investments Co. raised its stake in shares of HCA Healthcare by 27.5% during the first quarter. Sei Investments Co. now owns 467,796 shares of the company’s stock worth $221,380,000 after buying an additional 100,764 shares during the last quarter. SEB Asset Management AB bought a new stake in shares of HCA Healthcare during the first quarter worth approximately $75,534,000. Darsana Capital Partners LP lifted its holdings in HCA Healthcare by 46.7% in the second quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock valued at $428,879,000 after buying an additional 350,000 shares during the period. Finally, Bank of America Corp DE bought a new position in HCA Healthcare in the second quarter valued at approximately $238,457,000. Institutional investors own 62.73% of the company’s stock.
Insider Transactions at HCA Healthcare
In related news, EVP Michael J. Schlosser sold 1,200 shares of the stock in a transaction that occurred on Wednesday, November 4th. The stock was sold at an average price of $494.65, for a total transaction of $593,580.00. Following the completion of the sale, the executive vice president directly owned 1,443 shares of the company’s stock, valued at approximately $713,779.95. This represents a 45.40% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Jon M. Foster sold 21,713 shares of HCA Healthcare stock in a transaction that occurred on Friday, November 6th. The shares were sold at an average price of $494.95, for a total transaction of $10,746,849.35. Following the completion of the transaction, the chief operating officer directly owned 10,000 shares in the company, valued at approximately $4,949,500. The trade was a 68.47% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 36,413 shares of company stock valued at $18,251,464 over the last 90 days. 1.50% of the stock is owned by company insiders.
HCA Healthcare Stock Up 0.3%
Shares of HCA stock opened at $505.82 on Thursday. HCA Healthcare, Inc. has a 12-month low of $353.99 and a 12-month high of $556.52. The firm has a fifty day moving average of $449.06 and a 200-day moving average of $445.81. The firm has a market capitalization of $105.66 billion, a price-to-earnings ratio of 16.76, a price-to-earnings-growth ratio of 1.68 and a beta of 1.11.
HCA Healthcare (NYSE:HCA – Get Free Report) last issued its quarterly earnings data on Tuesday, October 27th. The company reported $7.22 EPS for the quarter, topping the consensus estimate of $6.65 by $0.57. The business had revenue of $19.85 billion for the quarter, compared to the consensus estimate of $19.33 billion. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The firm’s revenue was up 3.6% compared to the same quarter last year. During the same quarter last year, the business posted $6.96 EPS. Research analysts expect that HCA Healthcare, Inc. will post 30.15 earnings per share for the current year.
HCA Healthcare Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 29th. Shareholders of record on Tuesday, December 15th will be issued a $0.78 dividend. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Tuesday, December 15th. HCA Healthcare’s dividend payout ratio is 10.34%.
More HCA Healthcare News
Here’s some of the latest news about HCA:
- Neutral Sentiment: A Yahoo Finance article examines what drove HCA shares higher, but the supplied information does not specify the catalyst. Article: What Really Drove HCA Stock Higher?
- Negative Sentiment: A report flags a potentially flat 2027 outlook and payer pressure, which could constrain expectations for future growth. Article: HCA Healthcare Stock Faces Flat 2027 Outlook
- Negative Sentiment: Senior Vice President Erica Rossitto sold 3,500 shares, reducing her stake by about 20.7%. One insider sale alone does not establish a change in company outlook, but may weigh on sentiment. Article: HCA Insider Sells 3,500 Shares
Analyst Ratings Changes
A number of research firms have commented on HCA. Leerink Partners reaffirmed an “outperform” rating and set a $492.00 target price on shares of HCA Healthcare in a report on Friday, September 18th. Barclays increased their price target on HCA Healthcare from $387.00 to $401.00 and gave the company an “equal weight” rating in a research note on Thursday, October 29th. BMO Capital Markets started coverage on HCA Healthcare in a research note on Tuesday, September 22nd. They set an “outperform” rating and a $495.00 price objective for the company. TD Cowen upped their price objective on HCA Healthcare from $460.00 to $486.00 and gave the company a “buy” rating in a report on Wednesday, October 28th. Finally, Oppenheimer cut their target price on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a research note on Monday, July 27th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $480.13.
Check Out Our Latest Report on HCA
About HCA Healthcare
HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.
See Also
- Five stocks we like better than HCA Healthcare
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
